Literature DB >> 33751496

Atypical hemolytic uremic syndrome due to DGKE mutation and response to eculizumab: lessons for the clinical nephrologist.

Danya Husain1, Brian Barron2, Anya Golkowski Barron2, Ibrahim Sandokji1,3, Olivera Marsenic4, Jillian K Warejko5.   

Abstract

Entities:  

Keywords:  Atypical hemolytic uremic syndrome (aHUS); Complement; Complement inhibitors; Genetics; Pediatrics

Mesh：

Substances：

Year:  2021        PMID： 33751496     DOI： 10.1007/s40620-020-00925-8

Source DB:  PubMed          Journal:  J Nephrol        ISSN： 1121-8428            Impact factor:   4.393


× No keyword cloud information.
  8 in total

1.  Cytogenetic assignment and physical mapping of the human DGKE gene to chromosome 17q22.

Authors:  T C Hart; J A Price; P L Bobby; M J Pettenati; V Shashi; C Von Kap Herr; T E Van Dyke
Journal:  Genomics       Date:  1999-03-01       Impact factor: 5.736

2.  Diagnostic Utility of Complement Serology for Atypical Hemolytic Uremic Syndrome.

Authors:  Meera Sridharan; Ronald S Go; Roshini S Abraham; Fernando C Fervenza; Sanjeev Sethi; Sandra C Bryant; Grant M Spears; David L Murray; Maria A V Willrich
Journal:  Mayo Clin Proc       Date:  2018-10       Impact factor: 7.616

3.  Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Authors:  Timothy H J Goodship; H Terence Cook; Fadi Fakhouri; Fernando C Fervenza; Véronique Frémeaux-Bacchi; David Kavanagh; Carla M Nester; Marina Noris; Matthew C Pickering; Santiago Rodríguez de Córdoba; Lubka T Roumenina; Sanjeev Sethi; Richard J H Smith
Journal:  Kidney Int       Date:  2016-12-16       Impact factor: 10.612

4.  Atypical haemolytic uraemic syndrome in a Japanese patient with DGKE genetic mutations.

Authors:  Toshiyuki Miyata; Yumiko Uchida; Toshiyuki Ohta; Kohtaro Urayama; Yoko Yoshida; Yoshihiro Fujimura
Journal:  Thromb Haemost       Date:  2015-05-28       Impact factor: 6.681

5.  Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics.

Authors:  Lianne M Geerdink; Dineke Westra; Joanna A E van Wijk; Eiske M Dorresteijn; Marc R Lilien; Jean-Claude Davin; Martin Kömhoff; Koen Van Hoeck; Amerins van der Vlugt; Lambertus P van den Heuvel; Nicole C A J van de Kar
Journal:  Pediatr Nephrol       Date:  2012-03-13       Impact factor: 3.714

6.  DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GN.

Authors:  Fatih Ozaltin; Binghua Li; Alysha Rauhauser; Sung-Wan An; Oguz Soylemezoglu; Ipek Isik Gonul; Ekim Z Taskiran; Tulin Ibsirlioglu; Emine Korkmaz; Yelda Bilginer; Ali Duzova; Seza Ozen; Rezan Topaloglu; Nesrin Besbas; Shazia Ashraf; Yong Du; Chaoying Liang; Phylip Chen; Dongmei Lu; Komal Vadnagara; Susan Arbuckle; Deborah Lewis; Benjamin Wakeland; Richard J Quigg; Richard F Ransom; Edward K Wakeland; Matthew K Topham; Nicolas G Bazan; Chandra Mohan; Friedhelm Hildebrandt; Aysin Bakkaloglu; Chou-Long Huang; Massimo Attanasio
Journal:  J Am Soc Nephrol       Date:  2012-12-28       Impact factor: 14.978

7.  Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome.

Authors:  Mathieu Lemaire; Véronique Frémeaux-Bacchi; Franz Schaefer; Murim Choi; Wai Ho Tang; Moglie Le Quintrec; Fadi Fakhouri; Sophie Taque; François Nobili; Frank Martinez; Weizhen Ji; John D Overton; Shrikant M Mane; Gudrun Nürnberg; Janine Altmüller; Holger Thiele; Denis Morin; Georges Deschenes; Véronique Baudouin; Brigitte Llanas; Laure Collard; Mohammed A Majid; Eva Simkova; Peter Nürnberg; Nathalie Rioux-Leclerc; Gilbert W Moeckel; Marie Claire Gubler; John Hwa; Chantal Loirat; Richard P Lifton
Journal:  Nat Genet       Date:  2013-03-31       Impact factor: 41.307

Review 8.  Complement therapy in atypical haemolytic uraemic syndrome (aHUS).

Authors:  Edwin K S Wong; Tim H J Goodship; David Kavanagh
Journal:  Mol Immunol       Date:  2013-06-28       Impact factor: 4.174
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.